ArticleCell death & disease2016

Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms.

L Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.